Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life
Recruiting · NCT07306468 · Observational (researchers observe without assigning treatment) · Lead sponsor: Çankırı Karatekin University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and bipolar disorder. These psychiatric conditions are associated with sedentary lifestyles, metabolic side effects of psychotropic medications, and increased comorbidity risks, all of which may negatively impact physical fitness and respiratory health. By assessing cardiorespiratory endurance, pulmonary parameters (FVC, FEV₁), and respiratory muscle strength in this population, the study seeks to identify physiological limitations and contribute to the development of more effective rehabilitation strategies. The findings may support multidisciplinary approaches to improving physical health and overall quality of life in individuals with severe mental illness.
Who can take part
Inclusion criteria
- Being volunteer for participation
- Being 18 to 65 age
Exclusion criteria
- Having any respiratory, cardiac, neurologic or orthopedic disease which may affect respiratory functions or exercise capacity
- Having any neuropsychiatric disease except schizophrenia or bipolar disorder
Where it is running
1 location listed.
- Çankırı Karatekin University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation - Çankırı, Çankırı, Turkey (Türkiye)